ArticleEJHaem2026

Comparative Efficacy and Safety of Bruton Tyrosine Kinase and Spleen Tyrosine Kinase Inhibitors in Immune Thrombocytopenia: A Network Meta-Analysis of Clinical Trials.

Ayah Abulehia et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.